Search results (697)
« Back to NewsNational registry launched to transform care for people at risk of type 1 diabetes
11 September 2025
A first-of-its-kind UK registry for children and adults who are at risk of type 1 diabetes has been launched at the University of Oxford.
First myeloma patient joins Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science trial of radioactive bone scan
11 September 2025
In a world first researchers at NDORMS are testing a new technology that could enable clinicians to better diagnose and treat myeloma.
Trial shows that suture repair fails to improve digital nerve injury outcomes
11 September 2025
The first ever trial of microsurgical suture repair vs nerve alignment for digital nerve injuries suggests suture repair does not improve outcomes.
Iron Levels Found to Play a Key Role in FLASH Radiotherapy’s Tissue-Sparing Effect
11 September 2025
Researchers in the Department of Oncology have uncovered new insights into how FLASH radiation therapy kills cancer cells while minimising damage to healthy tissues. Published in Cell Death & Disease, the study shows the key role of iron levels in FLASH radiotherapy's tissue-sparing effect.
New recommendations from the ongoing national enquiries into maternal health and care in the UK
11 September 2025
The MBRRACE-UK collaboration, co-led by Oxford Population Health’s National Perinatal Epidemiology Unit, has today published the full Saving Lives, Improving Mothers’ Care report on women who died during or up to a year after pregnancy between 2021 and 2023.
Body-in-a-chip approach reveals how immune cells respond to heart injury
11 September 2025
Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.
World Suicide Prevention Day: latest research
10 September 2025
The Centre for Suicide Research investigates the extent, nature and causes of self-harm and suicide, with the aim of translating the findings into implications for prevention, treatment and support.
New Study Evaluates Effectiveness of Cancer Diagnosis Pathway for Patients with Non-Specific Symptoms
10 September 2025
A major UK study, led by researchers at the University of Oxford’s Nuffield Department of Primary Care Health Sciences, Oxford University Hospitals NHS Foundation Trust, the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre, and Oxford Cancer, has provided the most comprehensive analysis to date of a cancer diagnosis pathway for patients presenting with non-specific symptoms (NSS), such as unexplained weight loss or fatigue.
High blood pressure in midlife is associated with an increased risk of vascular dementia
9 September 2025
Evidence from the Million Women Study has shown that women who have hypertension (high blood pressure) in their 50s or 60s are at increased risk of developing vascular dementia in their 70s or 80s. The study is published in Alzheimer’s and Dementia.
Long-term trial results show surgery and stenting are equally protective against stroke
9 September 2025
Long-term results from the largest randomised trial of stenting and surgery have shown that the procedures are equally protective against stroke resulting from carotid artery disease.
New research identifies Galectin-3 as a key regulator of neural development, establishing its contribution to brain growth
5 September 2025
Luana Soares, Francis Szele and colleagues from Oncology (Eric O’Neill), from Paediatrics (Mathew Wood) and from DPAG (Zoltan Molnar, Mootaz Salman), have identified Galectin-3 as a key regulator of neural development, establishing its contribution to brain growth.
Outstanding early-career researchers awarded European Research Council funding to launch their ideas
4 September 2025
Today, eleven researchers at the University of Oxford have been selected to receive prestigious European Research Council (ERC) Starting Grants, each worth €1.5 million for a period of up to five years.
Research finds therapeutic potential for PEPITEM in osteoporosis
4 September 2025
Researchers have identified bioactive peptide sequences in PEPITEM molecules, and demonstrated the biological activity of the full PEPITEM molecule in counteracting key changes caused by osteoporosis.
New ‘off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukaemia
3 September 2025
Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukaemia.
Oxford launches major new AI vaccine research programme with the Ellison Institute of Technology
2 September 2025
The University of Oxford, through its strategic partnership with the Ellison Institute of Technology (EIT), has received research funding of £118m to launch an ambitious new programme of vaccine research.
Digital CBTe: A promising digital treatment for binge eating
2 September 2025
An innovative digital treatment programme for binge eating, Digital CBTe, has shown significant benefits in multiple pilot studies.
New studies reveal optimal time intervals for COVID-19 vaccine boosters
2 September 2025
Two new papers from scientists in the Nuffield Department of Medicine and other University of Oxford institutions have shown how the immune system reacts differently depending on the length of interval between vaccine doses.
The Kaiya Foundation to fund leukaemia research at University of Oxford
2 September 2025
The Kaiya Foundation has awarded one of its first major research grants, which will fund pioneering research into the fundamental cause of a high-risk leukaemia. The grant is being made to Dr Emily Neil and Professor Anindita Roy from the Childhood Leukaemia Research Group, based at the University of Oxford, in the hope that their discoveries will transform treatment approaches for sufferers through personalised medicine.
Teenage period pain linked to higher risk of chronic pain in adulthood
1 September 2025
Teenagers who experience moderate or severe period pain are significantly more likely to develop chronic pain in adulthood – including pain beyond the pelvis – according to a major new study from the University of Oxford, funded by the Medical Research Foundation.
Oxford-led team awarded significant grant to improve kidney transplant decision-making with AI
30 August 2025
Researchers from the Centre for Evidence in Transplantation (CET), led by Associate Professor Simon Knight, have been awarded a prestigious five-year National Institute for Health Research (NIHR) Programme Grant for Applied Research (PGfAR). The project will develop and evaluate AI-driven clinical decision support tools to help clinicians make better-informed choices about kidney transplant offers.